| Control (n = 21) | OSAS (n = 22) | P value |
---|---|---|---|
Demographics | |||
 Age (yrs.) | 64 (57–72) | 66 (60–76) | 0.50 |
 Gender (female/male) | 13/8 | 4/18 | 0.004 |
 Body weight (kg) | 74 (61–100) | 90 (74–112) | 0.0002 |
 Height (cm) | 168 (155–183) | 177 (159–188) | 0.006 |
 Body mass index (kg m− 2) | 27 (22–35) | 29 (23–38) | 0.037 |
 ASA classification (I/II/III) | 2/16/3 | 0/16/6 | 0.23 |
 STOP-BANG score | 2 (1–2) | 5 (3–7) |  |
Comorbidities | |||
 History of smoking | 6 | 10 | 0.48 |
 Diabetes mellitus | 1 | 4 | 0.16 |
Surgery | |||
 Otorhinolaryngologic surgery | 13 | 12 |  |
 Other type of Surgery | 8 | 10 |  |
Operation data | |||
 Duration of operation (min) | 70 (25–186) | 76 (17–195) | 0.61 |
 Duration of anaesthesia (min) | 113 (39–330) | 140 (42–236) | 0.38 |
 SpO2 before procedure (%) | 97 (92–100) | 96 (92–100) | 0.059 |
 SpO2 at extubation (%) | 99 (91–100) | 100 (81–100) | 0.97 |
 SpO2 at arrival intermediate care (%) | 96 (88–100) | 93 (88–98) | 0.080 |
 SpO2 lowest level (%) | 91 (70–98) | 92 (72–99) | 0.72 |
 Propofol dose (mg kg− 1 h− 1) | 6.18 (5.45–11.7) | 5.84 (0.84–7.03) | 0.11 |
 Remifentanil dose (μg kg− 1 min− 1) | 0.16 (0.11–0.33) | 0.17 (0.09–0.23) | 0.64 |